Absci Corp is trading 5.65% up today at $6.92, extending a recovery trend that began following recent investor conference presentations and news flow.
- The stock continues to show momentum follow-through and dip-buying interest after closing at $6.55 on June 8 following a volatile week.
- With no new earnings or FDA events reported for June 9, the price action is primarily attributed to improved market sentiment and increased company visibility.